Literature DB >> 20110920

Serum ferritin levels correlate with hypertensive retinopathy.

Erkan Coban1, Erhan Alkan, Seher Altuntas, Yusuf Akar.   

Abstract

BACKGROUND: In recent years several studies showed an association between body iron stores, represented by serum ferritin, and oxidative stress. The pathophysiological mechanism of hypertensive retinopathy (HR) is not fully established. Elevated blood pressure alone does not fully account for the extent of retinopathy; other pathogenic mechanisms may be involved, such as increased oxidative stress. Therefore this study was designed to determine whether ferritin levels change in HR and whether there is any relationship between the degree of HR and ferritin level. MATERIAL/
METHODS: This study included 72 essential hypertensive patients with HR. The hypertensive patients were divided into two groups according to the Keith-Wagener classification. Group 1 comprised 36 patients with grade I HR and group 2 36 patients with grade II HR Thirty-six normotensive healthy subjects matched for age, sex, and body mass index were selected for the control group.
RESULTS: The level of ferritin in group 2 was significantly higher than in group 1 (92.9+/-31.8 vs. 77.8+/-23.7 ng/ml, p=0.027) and the normotensive control group (92.9+/-31.8 vs. 59.9+/-19.2 ng/ml, p=0.001). It was also higher in group 2 than in the control group (77.8+/-23.7 vs. 59.9+/-19.2 ng/ml, p=0.018). Ferritin level also showed positive correlation with the degree of HR in the hypertensive group (r=0.31, p=0.026).
CONCLUSIONS: This study suggests that there is a relationship between HR and ferritin level, which may be associated with an increased level of oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20110920

Source DB:  PubMed          Journal:  Med Sci Monit        ISSN: 1234-1010


  8 in total

1.  Consideration of hypertensive retinopathy as an important end-organ damage in patients with hypertension.

Authors:  S A M Kolman; A M van Sijl; F A van der Sluijs; M A van de Ree
Journal:  J Hum Hypertens       Date:  2016-07-28       Impact factor: 3.012

2.  Study of ischemia modified albumin (IMA) as a biomarker in hypertensive retinopathy.

Authors:  Ecaterina Pavlovschi; Valeriana Pantea; Djina Borovic; Olga Tagadiuc
Journal:  Med Pharm Rep       Date:  2021-04-29

Review 3.  Hypertensive eye disease.

Authors:  Carol Y Cheung; Valérie Biousse; Pearse A Keane; Ernesto L Schiffrin; Tien Y Wong
Journal:  Nat Rev Dis Primers       Date:  2022-03-10       Impact factor: 52.329

4.  Lack of association between the c.544G>A polymorphism of the heme oxygenase-2 gene and age-related macular degeneration.

Authors:  Daniel Wysokinski; Ewelina Synowiec; Marta Chmielewska; Katarzyna Wozniak; Małgorzata Zaras; Anna Sklodowska; Janusz Blasiak; Jerzy Szaflik; Jacek Pawel Szaflik
Journal:  Med Sci Monit       Date:  2011-08

5.  Effects of phlebotomy-induced reduction of body iron stores on metabolic syndrome: results from a randomized clinical trial.

Authors:  Khosrow S Houschyar; Rainer Lüdtke; Gustav J Dobos; Ulrich Kalus; Martina Broecker-Preuss; Thomas Rampp; Benno Brinkhaus; Andreas Michalsen
Journal:  BMC Med       Date:  2012-05-30       Impact factor: 8.775

6.  The association between endothelial dysfunction and hypertensive retinopathy in essential hypertension.

Authors:  Mustafa Karaca; Erkan Coban; Sebahat Ozdem; Mustafa Unal; Ozan Salim; Orhan Yucel
Journal:  Med Sci Monit       Date:  2014-01-19

7.  Glutathione-related antioxidant defense system in patients with hypertensive retinopathy.

Authors:  Pavlovschi Ecaterina; Pantea Valeriana; Borovic Djina; Tagadiuc Olga
Journal:  Rom J Ophthalmol       Date:  2021 Jan-Mar

Review 8.  Impact of Arterial Hypertension on the Eye: A Review of the Pathogenesis, Diagnostic Methods, and Treatment of Hypertensive Retinopathy.

Authors:  Jacek Dziedziak; Anna Zaleska-Żmijewska; Jacek Paweł Szaflik; Agnieszka Cudnoch-Jędrzejewska
Journal:  Med Sci Monit       Date:  2022-01-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.